You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-CDKN1A (CDKN1A) Antibodies

Full name:
anti-Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) Antibodies (CDKN1A)
On are 565 Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) (CDKN1A) Antibodies from 23 different suppliers available. Additionally we are shipping CDKN1A Proteins (14) and CDKN1A Kits (12) and many more products for this protein. A total of 628 CDKN1A products are currently listed.
CAP20, CCND1, CDKI, Cdkn1, CDKN1A, CIP1, MDA-6, mda6, p16Xic2, P21, p21Cip1, p21WAF, SDI1, si:ch1073-48m5.2, UV96, WAF1
list all antibodies Gene Name GeneID UniProt
CDKN1A 114851  
CDKN1A 1026 P38936
CDKN1A 12575 P39689

Show all species

Show all synonyms

All available anti-CDKN1A Antibodies

Go to our pre-filtered search.

Top referenced anti-CDKN1A Antibodies

  1. Human Polyclonal CDKN1A Primary Antibody for FACS, IF - ABIN391763 : Fukuchi, Nakamura, Ichimura, Tatsumi, Gomi: The association of cyclin A and cyclin kinase inhibitor p21 in response to gamma-irradiation requires the CDK2 binding region, but not the Cy motif. in Biochimica et biophysica acta 2003 (PubMed)
    Show all 5 references for ABIN391763

  2. Human Polyclonal CDKN1A Primary Antibody for DB, EIA - ABIN358179 : Scott, Kimura, Dong, Ichinohasama, Bergen, Kerviche, Sheridan, DeCoteau: Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia. in Leukemia research 2004 (PubMed)
    Show all 5 references for ABIN358179

  3. Human Polyclonal CDKN1A Primary Antibody for EIA, IHC (p) - ABIN358182 : Amini, Saunders, Kelley, Khalili, Sawaya: Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes. in The Journal of biological chemistry 2004 (PubMed)
    Show all 5 references for ABIN358182

  4. Human Polyclonal CDKN1A Primary Antibody for EIA, IHC (p) - ABIN359673 : Frouin, Maga, Denegri, Riva, Savio, Spadari, Prosperi, Scovassi: Human proliferating cell nuclear antigen, poly(ADP-ribose) polymerase-1, and p21waf1/cip1. A dynamic exchange of partners. in The Journal of biological chemistry 2003 (PubMed)
    Show all 5 references for ABIN359673

  5. Human Polyclonal CDKN1A Primary Antibody for IF, WB - ABIN653259 : Chen, Turner, McCarthy, Scaltriti, Bettuzzi, Yeatman: Clusterin-mediated apoptosis is regulated by adenomatous polyposis coli and is p21 dependent but p53 independent. in Cancer research 2004 (PubMed)
    Show all 3 references for ABIN653259

  6. Human Polyclonal CDKN1A Primary Antibody for WB - ABIN655723 : Noma, Kirino, Ikeuchi, Suzuki: Biosynthesis of wybutosine, a hyper-modified nucleoside in eukaryotic phenylalanine tRNA. in The EMBO journal 2006 (PubMed)
    Show all 2 references for ABIN655723

  7. Human Monoclonal CDKN1A Primary Antibody for FACS, IHC (p) - ABIN180466 : Buckley, Sweeney, Hamilton, Sini, Manning, Nicholson, deFazio, Watts, Musgrove, Sutherland: Expression and amplification of cyclin genes in human breast cancer. in Oncogene 1993 (PubMed)
    Show all 2 references for ABIN180466

  8. Human Polyclonal CDKN1A Primary Antibody for DB, IHC (p) - ABIN389612 : Marqués, Kumar, Poveda, Zuluaga, Hernández, Jackson, Pasero, Carrera: Specific function of phosphoinositide 3-kinase beta in the control of DNA replication. in Proceedings of the National Academy of Sciences of the United States of America 2009 (PubMed)

  9. Human Polyclonal CDKN1A Primary Antibody for IF, IHC (p) - ABIN657391 : Hu, Gartenhaus, Eichberg, Liu, Fang, Rapoport: PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21. in Oncogene 2010 (PubMed)

More Antibodies against CDKN1A Interaction Partners

Zebrafish Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) (CDKN1A) interaction partners

  1. intestinal clock controls the expression of key cell cycle regulators, such as cdc2 (show CDK1 Antibodies), wee1 (show WEE1 Antibodies), p21, PCNA (show PCNA Antibodies) and cdk2 (show CDK2 Antibodies), but only weakly influences cyclin B1 (show CCNB1 Antibodies), cyclin B2 (show CCNB2 Antibodies) and cyclin E1 (show CCNE1 Antibodies) expression.

Human Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) (CDKN1A) interaction partners

  1. These findings demonstrated that p21 plays a critical role in furazolidone-induced apoptosis in HepG2 cells by influencing the caspase-3 (show CASP3 Antibodies) activation and ROS (show ROS1 Antibodies) generation.

  2. results suggested that high CDKN1A/p21 and low TGFBR2 (show TGFBR2 Antibodies) expression was closely correlated with adverse pathological parameters and poor prognosis in breast cancer.

  3. Study provides evidence that miR (show MLXIP Antibodies)-208a can affect the proliferation and radio-sensitivity of human lung cancer cells by targeting p21.

  4. Neisseria meningitidis caused changes in the abundance of several cell cycle regulatory mRNAs, including the cell cycle inhibitors p21(WAF1/CIP1) and cyclin G2 (show CCNG2 Antibodies) in human brain microvascular endothelial cells.

  5. Estrogen-related receptor gamma (show ESRRG Antibodies) is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27 (show PAK2 Antibodies).

  6. accumulation of HDAC4 (show HDAC4 Antibodies) induced by fibrillar collagen matrices in the nucleus via co-localization of PP1alpha (show PPP1CA Antibodies), leads to repression of the mRNA/protein of p21 and in turn promotes the proliferation and migration of epithelial ovarian cancer cells

  7. Clioquinol suppressed cell cycle progression in the S-phase in SMMC-7721 hepatoma cells via the p21, p27 (show PAK2 Antibodies)-cyclin E (show CCNE1 Antibodies),A/Cdk2 (show CDK2 Antibodies) pathway.

  8. Suggest that the p53 (show TP53 Antibodies)-p21-DREAM-CDE/CHR pathway regulates p53 (show TP53 Antibodies)-dependent repression of Survivin (show BIRC5 Antibodies), CDC25C (show CDC25C Antibodies), and PLK1 (show PLK1 Antibodies) in HCT116 cells.

  9. Overexpression of miR (show MLXIP Antibodies)-512-5p led to the decrease of p21 protein (show NRAS Antibodies).

  10. Data show CGK733 induced microtubule associated protein LC3B (show MAP1LC3B Antibodies) formation upstream of AMP-activated protein kinase (show PRKAA2 Antibodies) and protein kinase (show CDK7 Antibodies) RNA-like endoplasmic reticulum kinase/CCAAT-enhancer-binding protein homologous protein (show DDIT3 Antibodies) pathways and p21 Cip1 expression.

Cow (Bovine) Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) (CDKN1A) interaction partners

  1. p21 expression reports on Bovine herpesvirus 4 replication and could represent a host cell defensive response to infection-associated cellular damage.

Mouse (Murine) Cyclin-Dependent Kinase Inhibitor 1A (p21, Cip1) (CDKN1A) interaction partners

  1. The lack of functional Waf1 is indispensable for maintaining self-renewal and pluripotency of embryonic stem cells.

  2. p27(Kip1 (show CDKN1B Antibodies)) and p21(Cip1) are insufficient for the proliferative inhibition of smooth muscle cells cultured in type 1 collagen.

  3. Foxo3 (show FOXO3 Antibodies) circular RNA retards cell cycle progression via forming ternary complexes with p21 (show D4S234E Antibodies) and CDK2 (show CDK2 Antibodies).

  4. TFAP2C (show TFAP2C Antibodies) in trophoblasts controls proliferation by repressing Cdkn1a and activating the MAPK (show MAPK1 Antibodies) pathway, further supporting differentiation of glycogen (show GYS1 Antibodies) cells by activating the AKT (show AKT1 Antibodies) pathway

  5. Interaction between ASPM (show ASPM Antibodies) and the Cdk2 (show CDK2 Antibodies)/Cyclin E (show CCNE1 Antibodies) complex regulated the Cyclin (show PCNA Antibodies) activity by modulating its ubiquitination and localization into the nucleus.

  6. we present evidence that VPA administration to mice increases hippocampal p21 (show D4S234E Antibodies) expression, accompanied by DNA demethylation at the distal CpG island.

  7. LKB1 (show STK11 Antibodies) mediates CDKN1A degradation in response to ultraviolet DNA damage.

  8. At high glucose concentrations in vitro, AdipoR1 (show ADIPOR1 Antibodies) regulated the survival of neural stem cells through the p53 (show TP53 Antibodies)/p21 (show D4S234E Antibodies) pathway and the proliferation- and differentiation-related factors of neural stem cells via TLX (show NR2E1 Antibodies).

  9. Phosphorylation of p53 (show TP53 Antibodies) by LRRK2 (show LRRK2 Antibodies) induces p21(WAF1/CIP1) expression and apoptosis.

  10. AMP-18 (show GKN1 Antibodies) appears to act through PI3K/AKT (show AKT1 Antibodies) pathways to increase p21 (show D4S234E Antibodies) phosphorylation, thereby reducing its nuclear accumulation to overcome the antiproliferative effects of TNF-alpha (show TNF Antibodies).

CDKN1A Antigen Profile

Antigen Summary

This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen (PCNA), a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation. Multiple alternatively spliced variants have been found for this gene.

Alternative names and synonyms associated with CDKN1A

  • cyclin-dependent kinase inhibitor 1A (p21, Cip1) (cdkn1a) antibody
  • cyclin-dependent kinase inhibitor 1 (cki1) antibody
  • cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A) antibody
  • cyclin-dependent kinase inhibitor 1A (cdkn1a) antibody
  • cyclin-dependent kinase inhibitor 1A (LOC100348489) antibody
  • cyclin-dependent kinase inhibitor 1A (Cdkn1a) antibody
  • cyclin-dependent kinase inhibitor 1A (p21, Cip1) (Cdkn1a) antibody
  • cyclin-dependent kinase inhibitor 1A (P21) (Cdkn1a) antibody
  • CAP20 antibody
  • CCND1 antibody
  • CDKI antibody
  • Cdkn1 antibody
  • CDKN1A antibody
  • CIP1 antibody
  • MDA-6 antibody
  • mda6 antibody
  • p16Xic2 antibody
  • P21 antibody
  • p21Cip1 antibody
  • p21WAF antibody
  • SDI1 antibody
  • si:ch1073-48m5.2 antibody
  • UV96 antibody
  • WAF1 antibody

Protein level used designations for CDKN1A

cyclin dependent kinase inhibitor p16Xic2 , cyclin-dependent kinase inhibitor 1 , cyclin D1 , cyclin-dependent kinase inhibitor 1A (p21, Cip1) , cip1 , p21 , waf1 , cyclin-dependent kinase inhibitor 1A , cyclin-dependent kinase inhibitor 1A (P21) , CDK-interacting protein 1 , CDK-interaction protein 1 , DNA synthesis inhibitor , melanoma differentiation associated protein 6 , wild-type p53-activated fragment 1 , p21/WAF1 , melanoma differentiation-associated protein , p21

492305 Xenopus laevis
606440 Zea mays
747442 Pan troglodytes
100038054 Xenopus (Silurana) tropicalis
100302083 Ovis aries
100151416 Danio rerio
100348489 Oryctolagus cuniculus
114851 Rattus norvegicus
1026 Homo sapiens
474890 Canis lupus familiaris
513497 Bos taurus
100152215 Sus scrofa
100720449 Cavia porcellus
493943 Felis catus
12575 Mus musculus
Selected quality suppliers for anti-CDKN1A (CDKN1A) Antibodies
Did you look for something else?